Tohid Emami Meybodi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tohid Emami Meybodi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ahmadreza Lagzian
Department of Biochemistry, the Graduate Center, City university of New York (CUNY, New York, NY, USA
1 shared publication - Alireza Askari
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Elham Paraandavaji
Skull Base Research Center, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication - Khatere Mokhtari
Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran
1 shared publication Mahboobeh Nikandish
Training unit, Amiralmomenin Hospital, Semnan University of Medical Science, Semnan, Iran
1 shared publication- Majid Eslami
Research Center of Physiology, Neuroscience Research Institute, Semnan University of Medical Sciences, Semnan, Iran
1 shared publication
Latest Publications
- 28 January 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 23
Redox signaling in the heart and brain: the roles of nitric oxide and reactive oxygen species in disease and therapy
Nitric oxide (NO) and reactive oxygen species (ROS) are central to the pathophysiology of cardiovascular and neurological disorders, influencing intricate signaling pathways that manage vascular function, inflammation, and oxidative stress. NO, predominantly produced by NO-synthases, plays a vital role in maintaining vascular health by facilitating vasodilation and preventing platelet aggregation. However, its reaction with superoxide results in the formation of peroxynitrite, a highly reactive molecule that intensifies oxidative damage and impairs endothelial function. Elevated ROS levels, arising from sources like NADPH oxidases and mitochondrial activity, further heighten oxidative stress, driving the progression of conditions like atherosclerosis and neurodegenerative diseases. Therapeutic strategies aimed at restoring the balance between NO and ROS include the use of antioxidants to neutralize ROS, pharmacological methods to enhance NO bioavailability, and nanoparticle-based systems designed to address oxidative stress. Emerging research points to potential of targeting redox-sensitive pathways, such as the Keap1-Nrf2 axis, to slow disease progression. In neurological disorders, overproduction of ROS leads to neuroinflammation and neuronal apoptosis, which are central to conditions like Alzheimer's and Parkinson's disease. This review explores the complex relationship between NO and ROS in disease mechanisms, emphasizing cutting-edge therapeutic strategies that utilize redox signaling in cardiovascular and neurological conditions.
- 28 January 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 23
Redox signaling in the heart and brain: the roles of nitric oxide and reactive oxygen species in disease and therapy
Nitric oxide (NO) and reactive oxygen species (ROS) are central to the pathophysiology of cardiovascular and neurological disorders, influencing intricate signaling pathways that manage vascular function, inflammation, and oxidative stress. NO, predominantly produced by NO-synthases, plays a vital role in maintaining vascular health by facilitating vasodilation and preventing platelet aggregation. However, its reaction with superoxide results in the formation of peroxynitrite, a highly reactive molecule that intensifies oxidative damage and impairs endothelial function. Elevated ROS levels, arising from sources like NADPH oxidases and mitochondrial activity, further heighten oxidative stress, driving the progression of conditions like atherosclerosis and neurodegenerative diseases. Therapeutic strategies aimed at restoring the balance between NO and ROS include the use of antioxidants to neutralize ROS, pharmacological methods to enhance NO bioavailability, and nanoparticle-based systems designed to address oxidative stress. Emerging research points to potential of targeting redox-sensitive pathways, such as the Keap1-Nrf2 axis, to slow disease progression. In neurological disorders, overproduction of ROS leads to neuroinflammation and neuronal apoptosis, which are central to conditions like Alzheimer's and Parkinson's disease. This review explores the complex relationship between NO and ROS in disease mechanisms, emphasizing cutting-edge therapeutic strategies that utilize redox signaling in cardiovascular and neurological conditions.
- 1 December 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 35 (4) , 396-405
The role of exosomes in bone tissue regeneration: signaling mechanisms and therapeutic potential – a mini review
- 1 December 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 35 (4) , 396-405
The role of exosomes in bone tissue regeneration: signaling mechanisms and therapeutic potential – a mini review